Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

2(33%)

Results Posted

67%(2 trials)

Terminated

1(17%)

Phase Distribution

Ph phase_4

33%

Ph phase_2

17%

Ph not_applicable

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

1(16.7%)

Phase 4Post-market surveillance

2(33.3%)

N/ANon-phased studies

3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (16.7%)

Phase 42 (33.3%)

N/A3 (50.0%)

Trials by Status

terminated117%

completed350%

recruiting117%

active_not_recruiting117%

Recent Activity

2 active trials

Showing 5 of 6

active_not_recruitingphase_2

CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)

NCT03167905

recruitingnot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT03167905Phase 2

CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)

Active Not Recruiting

NCT06557642Not Applicable

Nitrous Oxide and EMOtional Cognition

Recruiting

NCT04321642Not Applicable

The Effect of Entonox on Stages of Labor in Nulliparous Women

Completed

NCT01744184Phase 4

A Single-centre Study of Entonox Versus Midazolam Sedation in Gastroscopy

Terminated

NCT01865721Phase 4

Optimizing the Use of Entonox® During Screening Colonoscopy

Completed

NCT01172600Not Applicable

Effect of Nitrous Oxide in Treating Neuropathic Pain: A Study in Chronic Low Back Pain Patients

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6